Financing
Repayments of Short-Term Debt
Year-over-year, this metric declined by 76.1%, from $1.08B to $259M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher repayments reduce short-term debt levels, which can lower interest expense but may signal a need for refinancing or reduced liquidity.
Detailed definition
Cash outflows used to settle the principal amount of debt obligations due within one year. This reflects the company's m...
Peer comparison
Standard metric for assessing short-term debt management across all public companies.
Metric ID:
financing_repayments_of_short_term_debtHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $250M | $0 | $0 | $0 | $0 | $504M | $1.08B | $500M | $12M | $0 | $259M |
| QoQ Change | — | — | — | — | -100.0% | — | — | — | — | +114.9% | -53.8% | -97.6% | -100.0% | — |
| YoY Change | — | — | — | — | -100.0% | — | — | — | — | +114.9% | — | — | — | -76.1% |
Range$0 – $1.08B
Avg YoY Growth-20.4%
Median YoY Growth-76.1%
Current Streak4 quarters decline
Repayments of Short-Term Debt at Other Companies
Frequently Asked Questions
- What is Boston Scientific's repayments of short-term debt?
- Boston Scientific (BSX) reported repayments of short-term debt of $259M in Q1 2026.
- How has Boston Scientific's repayments of short-term debt changed year-over-year?
- Boston Scientific's repayments of short-term debt decreased by 76.1% year-over-year, from $1.08B to $259M.
- What does repayments of short-term debt mean?
- Cash used to pay off short-term loans or debt obligations.